Clinical Trial Update: Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating radiotherapy planning guided by 18F-fluorodeoxyglucose positron emission tomography for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN